121 related articles for article (PubMed ID: 11311855)
1. Oxygen modulates the release of urokinase and plasminogen activator inhibitor-1 by retinal pigment epithelial cells.
Erichsen JT; Jarvis-Evans J; Khaliq A; Boulton M
Int J Biochem Cell Biol; 2001 Mar; 33(3):237-47. PubMed ID: 11311855
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta induces urokinase receptor expression in cultured retinal pigment epithelial cells.
Sirén V; Myöhänen H; Vaheri A; Immonen I
Ophthalmic Res; 1999; 31(3):184-91. PubMed ID: 10224501
[TBL] [Abstract][Full Text] [Related]
3. Modulation of plasminogen activator inhibitor-1 and urokinase in retinal pigmented epithelial cells.
Hackett SF; Campochiaro PA
Invest Ophthalmol Vis Sci; 1993 May; 34(6):2055-61. PubMed ID: 8491554
[TBL] [Abstract][Full Text] [Related]
4. Alpha- and gamma-interferon inhibit plasminogen activator inhibitor-1 gene expression in human retinal pigment epithelial cells.
Sirén V; Immonen I; Cantell K; Vaheri A
Ophthalmic Res; 1994; 26(1):1-7. PubMed ID: 8134084
[TBL] [Abstract][Full Text] [Related]
5. Retinal pigment epithelial cells secrete urokinase-type plasminogen activator and its inhibitor PAI-1.
Sirén V; Stephens RW; Salonen EM; Vaheri A; Summanen P; Immonen I
Ophthalmic Res; 1992; 24(4):203-12. PubMed ID: 1436981
[TBL] [Abstract][Full Text] [Related]
6. Effect of transforming growth factor-beta 1 on plasminogen activators and plasminogen activator inhibitor-1 in renal glomerular cells.
Wilson HM; Reid FJ; Brown PA; Power DA; Haites NE; Booth NA
Exp Nephrol; 1993; 1(6):343-50. PubMed ID: 8081986
[TBL] [Abstract][Full Text] [Related]
7. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
8. Retinoids increase urokinase-type plasminogen activator production by human retinal pigment epithelial cells in culture.
Immonen I; Sirén V; Stephens RW; Liesto K; Vaheri A
Invest Ophthalmol Vis Sci; 1993 May; 34(6):2062-7. PubMed ID: 8491555
[TBL] [Abstract][Full Text] [Related]
9. TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.
Sugioka K; Kodama A; Okada K; Iwata M; Yoshida K; Kusaka S; Matsumoto C; Kaji H; Shimomura Y
Exp Eye Res; 2013 Oct; 115():13-21. PubMed ID: 23810810
[TBL] [Abstract][Full Text] [Related]
10. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
[TBL] [Abstract][Full Text] [Related]
11. Tissue- and urokinase-type plasminogen activators and type 1 plasminogen activator inhibitor in melanomas and benign skin pigment neoplasms.
Gershtein ES; Medvedeva SV; Babkina IV; Kushlinskii NE; Trapeznikov NN
Bull Exp Biol Med; 2001 Jul; 132(1):670-4. PubMed ID: 11687850
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells.
Arnoletti JP; Albo D; Granick MS; Solomon MP; Castiglioni A; Rothman VL; Tuszynski GP
Cancer; 1995 Sep; 76(6):998-1005. PubMed ID: 8625226
[TBL] [Abstract][Full Text] [Related]
13. Secretion of plasminogen activators by cells cultured from subretinal fluid.
Sirén V; Vaheri A; Immonen I
Acta Ophthalmol (Copenh); 1994 Apr; 72(2):218-22. PubMed ID: 8079628
[TBL] [Abstract][Full Text] [Related]
14. Regulation of plasminogen activation by TGF-beta in cultured human retinal endothelial cells.
Wileman SM; Booth NA; Moore N; Redmill B; Forrester JV; Knott RM
Br J Ophthalmol; 2000 Apr; 84(4):417-22. PubMed ID: 10729302
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of urokinase-type plasminogen activator and its receptor correlates with enhanced invasion activity of human glioma cells mediated by transforming growth factor-alpha or basic fibroblast growth factor.
Mori T; Abe T; Wakabayashi Y; Hikawa T; Matsuo K; Yamada Y; Kuwano M; Hori S
J Neurooncol; 2000; 46(2):115-23. PubMed ID: 10894364
[TBL] [Abstract][Full Text] [Related]
16. Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells.
Sprague LD; Tomaso H; Mengele K; Schilling D; Bayer C; Stadler P; Schmitt M; Molls M
Oncol Rep; 2007 May; 17(5):1259-68. PubMed ID: 17390074
[TBL] [Abstract][Full Text] [Related]
17. Urokinase and type I plasminogen activator inhibitor production by normal human hepatocytes: modulation by inflammatory agents.
Busso N; Nicodeme E; Chesne C; Guillouzo A; Belin D; Hyafil F
Hepatology; 1994 Jul; 20(1 Pt 1):186-90. PubMed ID: 8020888
[TBL] [Abstract][Full Text] [Related]
18. Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system.
Fibbi G; D'Alessio S; Pucci M; Cerletti M; Del Rosso M
Biol Chem; 2002 Jan; 383(1):127-36. PubMed ID: 11928807
[TBL] [Abstract][Full Text] [Related]
19. Cytokines may influence tumor growth and spread. An in vitro study in two human cancer cell lines.
Panozzo MP; Basso D; De Paoli M; Carraro P; Burighel D; Plebani M
Int J Clin Lab Res; 1996; 26(4):240-4. PubMed ID: 9007614
[TBL] [Abstract][Full Text] [Related]
20. Expression pattern of the urokinase-plasminogen activator system in rat DS-sarcoma: role of oxygenation status and tumour size.
Weinmann M; Thews O; Schroeder T; Vaupel P
Br J Cancer; 2002 Apr; 86(8):1355-61. PubMed ID: 11953898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
